Abstract: Embodiments are directed to catalyst systems comprising: a procatalyst; and a co-catalyst dissolved in a non-halogenated aprotic hydrocarbon solvent, the co-catalyst comprising: a non-coordinating borate dianion having the formula: (III) and two cations, each cation being independently chosen from a cation according to formula (I) or formula (II).

Abstract: The present invention provides systems, devices, signaling polynucleotides (SPNs), detection agents and methods for detecting the presence and/or absence of one or more allergens in a sample particularly a food sample. The detection system includes a separate sampler, at least one disposable detection vessel for receiving and processing a test sample and a detection device for measuring a fluorescent signal. SPNs derived from aptamer that bind allergens are provided as detection agents. SPNs have a single open structure, and are labeled with a fluorophore. Changes in fluorescence polarization of SPNs upon the binding of allergens are measured to calculate the allergen content in a sample.

Abstract: Aspects of the invention include providing intelligent content recommendations to groups of people. A non-limiting example computer-implemented method includes identifying, by a processor, the presence of a plurality of users in a location. The method creates a virtual user with a virtual user profile, by the processor, from profiles of the plurality of users and provides, by the processor, a recommendation to the plurality of users of content to consume based on the virtual user's profile. The method serves, by the processor, the recommended content.

Abstract: Technologies for performing an automated application exchange negotiation in an operator network include an endpoint device, a mobile edge computing device, a core computing device, an application provider computing device, and a network operator computing device. The mobile edge computing device is configured to receive a request to access an application and/or service stored at the mobile edge computing device and/or the application provider computing device. The mobile edge computing device is further configured to initiate the automated application exchange negotiation between the application provider computing device and the network operator computing device to determine one or more terms of the negotiation, including one or more terms of a service level agreement (SLA). Other embodiments are described herein.

Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.

Abstract: The present invention relates to a bitumen recovery process from oil sands. The oil sands may be surface mined and transported to a treatment area or may be treated directly by means of an in situ process of oil sand deposits that are located too deep for strip mining. Specifically, the present invention involves the step of treating oil sands with a composition comprising an alkanolamine and an ethylene oxide capped glycol ether and/or propylene oxide capped glycol ether.

Abstract: An electrocardiograph system including a monitoring device capable of receiving cardiac signals from electrodes attached to a patient in an alternative electrode configuration, wherein the alternative electrode configuration is one of a predetermined set of known electrode configurations that differs from a default configuration. The system further includes an analysis module configured to analyze the cardiac signals to detect that the electrodes are attached to the patient in an electrode configuration that differs from the default configuration, and then request information from the user identifying the alternative electrode configuration from the predetermined set of known electrode configurations. The analysis module retrieves a set of criteria for assessing the cardiac signals based on the alternative electrode configuration, and automatically analyzes the cardiac signals based on the set of criteria for the alternative electrode configuration.

Abstract: A method for processing ECG records from multiple patients for clinician overreading includes identifying an unread group of current ECG records from multiple patients awaiting clinician overreading. Each ECG record in the ungroup includes at least a current ECG data, a current waveform measurement, a current interpretative statement, and a serial comparison statement. A set of prioritization rules is applied with a processor to prioritize the current ECG records in the unread group into a prioritized order for clinician overreading based on at least one of the current waveform measurements, the current interpretive statements, and the serial comparison statements. The current ECG records are then presented in the prioritized order for clinician overreading.

Abstract: A selective microbial detection device and methods of use are provided. The device includes a water-proof pouch that includes a first wall portion, a second wall portion, and a porous membrane filter disposed in the pouch between the first and second wall portions. The filter membrane divides the pouch into first and second compartments. The microbial detection device also includes an effective amount of a dry nutrient disposed in the first compartment, which contains sodium lauryl sulfate in an amount of 1.75 milligrams or greater per twelve square inches of the first wall portion. A dry, cold water-soluble gelling agent is adhered to the pouch in the first compartment and an absorbent pad is disposed in the second compartment. A sealable sample port provides access to deposit a liquid into the first compartment.

Abstract: The present invention provides systems, devices, signaling polynucleotides (SPNs), detection agents and methods for detecting the presence and/or absence of one or more allergens in a sample particularly a food sample. The detection system includes a separate sampler, at least one disposable detection vessel for receiving and processing a test sample and a detection device for measuring a fluorescent signal. SPNs derived from aptamer that bind allergens are provided as detection agents. SPNs have a single open structure, and are labeled with a fluorophore. Changes in fluorescence polarization of SPNs upon the binding of allergens are measured to calculate the allergen content in a sample.

Abstract: Embodiments are directed to catalyst systems comprising: a procatalyst; and a co-catalyst, the co-catalyst comprising: a non-coordinating borate anion having the formula [B(C6F5)4]1? and a cation according to formula (I).

Abstract: Examples describe an egress subsystem that can be used to schedule fetching and transmission of packets from a switch fabric. Segments of a packet can be requested from a switch fabric and stored in a re-order buffer to re-order any segments that are received out of order from the switch fabric. A header segment re-order buffer can be used to re-order segments of a header. After a header of a packet is available in the header segment re-order buffer, the header can be processed before the entire associated body is received from the switch fabric. A jitter threshold scheme can gate egress of a body from a re-order buffer unless a time threshold or amount threshold is met. The egress subsystem can track a state of packet segments from request to transmission, A flow control message received at the egress subsystem can cause packets in certain states to be paused and not permitted to egress.

Abstract: A medical system includes an input assembly for receiving one or more user inputs. The input assembly includes at least one slider assembly for providing an input signal. Processing logic receives the input signal from the input assembly and provides a first output signal and a second output signal. A display assembly is configured to receive, at least in part, the first output signal from the processing logic and render information viewable by the user. The second output signal is provided to one or more medical system components. The information rendered on the display assembly may be manipulatable by the user and at least a portion of the information rendered may be magnified.

Abstract: The current disclosure provides methods for reprogramming mammalian somatic cells by regulating the expression of endogenous cellular genes. Cellular reprogramming of somatic cells can be induced by activating the transcription of embryonic stem cell-associated genes (e.g., oct3/4) and suppressing the transcription of somatic cell-specific and/or cell death-associated genes. The endogenous transcription machinery can be modulated using synthetic transcription factors (activators and suppressors), to allow for faster, and more efficient nuclear reprogramming under conditions amenable for clinical and commercial applications. The current disclosure further provides cells obtained from such methods, along with therapeutic methods for using such cells for the treatment of diseases amendable to stem cell therapy, as well as kits for such uses.

Abstract: Further described herein are extensions to the basic concept of LHs as electrode materials, include both new materials for use with LHs and higher order poly-layer hydroxides (PLHs) as well as methods for synthesizing improved LH material such as with conductive supports or through the use of cross-linking. Finally, also described herein are embodiments enabling the use of LHs as flow electrodes as well as the use of 2-d LH materials for surface redox reactions.

Abstract: A method and system for setting time blocks of a repeating time period is disclosed. The method and system may be a part of a healthcare management software system.

Abstract: A method for optimizing a Hegman rating of a diluted emulsion including adjusting the shear work in the dilution mixer, wherein the adjusting the shear work may comprise raising or lowering the shear work; adjusting the temperature of the concentrated and/or diluted emulsion; if not earlier added, adding a basic aqueous solution and/or dispersing agent; adding one or more other additives; and/or adjusting the amount of any additive, basic solution or surfactant solution is provided. Also provided are diluted emulsions produced thereby and coatings made from the diluted emulsions.

Abstract: Systems and methods for nitric oxide (NO) generation systems are provided. In some embodiments, an NO generation system comprises at least one pair of electrodes configured to generate a product gas containing NO from a flow of a reactant gas. The electrodes have elongated surfaces such that a plasma produced is carried by the flow of the reactant gas and glides along the elongated surfaces from a first end towards a second end of the electrode pair. A controller is configured to regulate the amount of NO in the product gas by the at least one pair of electrodes using one or more parameters as an input to the controller. The one or more parameters include information from a plurality of sensors configured to collect information relating to at least one of the reactant gas, the product gas, and a medical gas into which the product gas flows.

Abstract: A method of obtaining and analyzing ECG data from a patient or group of patients is disclosed. The ECG data is obtained from the patient at an acquisition device. Once the ECG data is obtained, the ECG data is transmitted to an analysis server that is operated by an analysis provider and is located remote from the location of the acquisition device. Along with the ECG data, acquisition parameters are transmitted to the analysis server. At the analysis server, one of a plurality of algorithms is selected to analyze the ECG data. If an abnormality is detected, the patient information is directed to a healthcare provider who can then contact the patient to schedule an appointment. Based upon the referral, a referral fee can be transferred from the healthcare provider to the analysis provider. The patient can be prompted to provide additional information and selections that dictate the level of analysis generated.

Abstract: The present invention relates to substantially homogenous populations of human retinal progenitor cells having the following positive surface markers: SSEA4, CD73, PTK7 and PSA-NCAM. The invention also relates to method for preparing such substantially homogeneous cell populations from human tissue using cell sorting techniques.